4
Changes in Ownership
Stoke Therapeutics, Inc. Filed Acc 0001415889-25-008713
Options or other derivatives
- Chief Financial Officer acquired 148,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Leggett Thomas Chief Financial Officer | 2025-03-20 | Grant or award · Employee Stock Option (Right to Buy) | +89,000 | 89,000 | D | ||
| Leggett Thomas Chief Financial Officer | 2025-03-20 | Grant or award · Restricted Stock Units | +59,000 | 59,000 | D | ||
Loading xslF345X05/form4-03202025_100358.xml…